GRIFFIN MICHAEL D
Known title: DirectorCIK: 0001045849
Associated companies
Transaction History
| RKLB | ▼ Sell | Open Market | 39,446 | $272K | 8/22/2024 | View on chart |
| RKLB | ▼ Sell | Other | 39,446 | $0 | 8/14/2024 | View on chart |
| RKLB | ▼ Sell | Other | 39,446 | $0 | 8/14/2024 | View on chart |
| RKLB | ▲ Buy | Grant | 42,353 | $0 | 6/12/2024 | View on chart |
| RKLB | ▼ Sell | Open Market | 38,090 | $242K | 8/30/2023 | View on chart |
| RKLB | ▼ Sell | Other | 38,090 | $0 | 6/16/2023 | View on chart |
| RKLB | ▲ Buy | Grant | 38,090 | $0 | 6/16/2023 | View on chart |
| RKLB | ▲ Buy | Grant | 39,446 | $0 | 6/14/2023 | View on chart |
| RKLB | ▼ Sell | Open Market | 50,689 | $253K | 6/6/2023 | View on chart |
| RKLB | ▼ Sell | Other | 50,689 | $0 | 5/25/2023 | View on chart |
| RKLB | ▼ Sell | Other | 50,689 | $0 | 5/25/2023 | View on chart |
| RKLB | ▼ Sell | Open Market | 50,689 | $223K | 5/17/2023 | View on chart |
| RKLB | ▼ Sell | Other | 50,689 | $0 | 3/1/2023 | View on chart |
| RKLB | ▼ Sell | Other | 50,689 | $0 | 3/1/2023 | View on chart |
| RKLB | ▼ Sell | Open Market | 50,688 | $209K | 12/12/2022 | View on chart |
| RKLB | ▼ Sell | Other | 50,688 | $0 | 11/28/2022 | View on chart |
| RKLB | ▼ Sell | Other | 50,688 | $0 | 11/28/2022 | View on chart |
| RKLB | ▼ Sell | Other | 456,190 | $0 | 9/9/2022 | View on chart |
| RKLB | ▼ Sell | Other | 456,190 | $0 | 9/9/2022 | View on chart |
| RKLB | ▼ Sell | Open Market | 456,190 | $2.6M | 9/9/2022 | View on chart |
| RKLB | ▲ Buy | Option Exercise | 608,256 | — | 9/6/2022 | View on chart |
| RKLB | ▲ Buy | Grant | 38,090 | $0 | 6/23/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Rocket Lab shares fall after Neutron rocket delay and target cut
Rocket Lab announced a delay to its Neutron launch vehicle, citing technical issues. Following the announcement, Citizens Research cut its price target to $90, noting the delay’s impact on launch revenue in fiscal years 2027 and 2028. The news coincided with a roughly 6% drop in the stock price, as reported by multiple outlets. Analysts continue to show a wide range of price expectations, with an average target of about $103.
Rocket Lab shares fall after Neutron rocket delay and target cut. Rocket Lab announced a delay to its Neutron launch vehicle, citing technical issues. Following the announcement, Citizens Research cut its price target to $90, noting the delay’s impact on launch revenue in fiscal years 2027 and 2028. The news coincided with a roughly 6% drop in the stock price, as reported by multiple outlets. Analysts continue to show a wide range of price expectations, with an average target of about $103.